Belchior Ana, Alves Bianca C, Mendes Edgar, Megre Francisco, Alves Luís C, Santos Pedro, Nishimura Kai, Nakamura Hiroyuki, Teixidor Francesc, Viñas Clara, Sampaio Jorge Miguel, Marques Fernanda, Pinheiro Teresa
Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, Bobadela LRS, 2695-066, Portugal.
Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, Bobadela LRS, 2695-066, Portugal.
EJNMMI Res. 2025 Feb 21;15(1):13. doi: 10.1186/s13550-025-01199-6.
Protons, which are considered low-LET (Linear Energy Transfer) radiation, have an average RBE (relative biological effectiveness) of 1.1, with a range from 0.7 to 1.6. Thus, increasing biological effectiveness is of high interest in radiation oncology, and one way to enhance this is by using radiosensitizers. The present work investigates the effectiveness of the proton boron fusion reaction (PBFR) at the cellular level, using the sodium salt of metallacarborane [3,3'-Co(C2B9H11)2] (Na[o-COSAN]) as the boron source, aiming to explore the potential of this type of boron clusters as a radiosensitizer for proton therapy. Therefore, the main goal was to test the hypothesis that loading the cells with boron will favour the PBFR at energies close to the Bragg peak. This would enhance the radiation-induced biological effects through the production of alpha-particles.
MDA-MB-231 breast cancer cells were used. Nuclear microscopy assessed [o-COSAN] uptake and distribution in single cells, while biodistribution was studied in tumor-bearing Balb/cSlc-nu/nu mice (MDA-MB-231 xenograft), with boron accumulation in target organs and tumor measured by ICP-OES. The cells were irradiated with a proton beam tuned to reach the PBFR resonance energy of 675 keV at the cell layer. DNA damage was assessed with the g-H2AX assay and cell survival with the clonogenic assay. Beam parameters and dose calibration curves using radiochromic films validated Monte Carlo dosimetry simulations. As expected, we observed higher biological damage in irradiated cells and the presence of [o-COSAN] potentiated the damage. These results translate into a lower cellular viability, indicating that DNA damage imposed colonies smaller than their non-irradiated counterparts. This suggests that these damages either took longer time to be repaired or made the cells undergo less efficient survival mechanisms.
The radiosensitizing effect of [o-COSAN] by strategic cellular B placement and proton irradiation intensifies the DNA damage, making the nucleus particularly susceptible and thus increasing the destructive capability of alpha-particles, generated in the nuclear fusion reaction, which may lead to increased cell mortality.
质子被认为是低传能线密度(LET)辐射,其平均相对生物效应(RBE)为1.1,范围在0.7至1.6之间。因此,提高生物效应在放射肿瘤学中备受关注,一种增强生物效应的方法是使用放射增敏剂。本研究在细胞水平上研究质子硼聚变反应(PBFR)的有效性,使用金属碳硼烷[3,3'-Co(C2B9H11)2]的钠盐(Na[o-COSAN])作为硼源,旨在探索这类硼簇作为质子治疗放射增敏剂的潜力。因此,主要目标是检验以下假设:在能量接近布拉格峰时,使细胞负载硼将有利于PBFR。这将通过产生α粒子增强辐射诱导的生物效应。
使用MDA-MB-231乳腺癌细胞。核显微镜评估单细胞中[o-COSAN]的摄取和分布,而在荷瘤Balb/cSlc-nu/nu小鼠(MDA-MB-231异种移植瘤)中研究生物分布,通过电感耦合等离子体发射光谱法(ICP-OES)测量靶器官和肿瘤中的硼积累。用调谐至在细胞层达到675 keV的PBFR共振能量的质子束照射细胞。用γ-H2AX检测评估DNA损伤,用克隆形成检测评估细胞存活。使用放射变色膜的束参数和剂量校准曲线验证了蒙特卡罗剂量学模拟。正如预期的那样,我们观察到受照射细胞中更高的生物损伤,并且[o-COSAN]的存在增强了损伤。这些结果转化为较低的细胞活力,表明DNA损伤使集落小于未受照射的对应物。这表明这些损伤要么需要更长时间来修复,要么使细胞经历效率较低的存活机制。
通过策略性的细胞硼放置和质子照射,[o-COSAN]的放射增敏作用加剧了DNA损伤,使细胞核特别敏感,从而增加了核聚变反应中产生的α粒子的破坏能力,这可能导致细胞死亡率增加。